TGA Approval

BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial (313680)

ARTG ID

313680

ARTG Name

BEOVU brolucizumab (rbe) 120 mg/mL solution for injection in vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

January 16, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/3d979f1621ac96e1327b2387969928db.pdf

Ingredient Name

brolucizumab

Empowering clinical research with data-driven insights and AI-powered tools.